AskAt received a Patent Registration Certificate dated July 27, 2023 from IP Australia for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The certificate was issued in connection with Australian Patent Application No. 2021380315 (Filing Date: November 11, 2021). On the registration of this patent, the patent right remains in force in Australia until November 11, 2041.
